Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
HMS-043 - Pharmacoeconomics of stem cell therapies for diabetes and neurodegenerative diseases: The role of clinical pharmacists in cost optimization
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: HMS-043
- By: ABOELELLA, Zahraa (Arab Academy For Science, Technology, And Martime Transport, Egypt)
- Co-author(s): Ms Zahraa Aboelella (Arab Academy For Science, Technology, And Martime Transport, Alexandria , Egypt)
Ms Nouran Soliman (Arab Academy For Science, Technology, And Martime Transport, Alexandria , Egypt) - Abstract:
Background Information
Diabetes and neurodegenerative diseases, such as Parkinson’s disease (PD), impose significant economic burdens on healthcare systems globally. For type 1 diabetes (T1D), the lifetime medical costs in the U.S. alone are estimated at 133.7 billion, with additional income losses of 289.2 billion. Traditional treatments,.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025